According to the press release from Eurofins Scientific, the company completed the purchase of 100,000 shares from November 10 to November 14, 2025. Each day, a volume of 20,000 shares was acquired. The weighted average price for these purchases varied daily: EUR 58.3855 on November 10, EUR 58.5144 on November 11, EUR 59.2288 on November 12, EUR 59.5191 on November 13, and finally EUR 58.7814 on November 14.
Regulatory Compliance
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
Almost there! Check your inbox.
A confirmation email has been sent. Click the link to confirm your subscription.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Eurofins Scientific specifies that these transactions are in accordance with Article 5(1)(b) of EU Regulation No. 596/2014, known as the Market Abuse Regulation. A detailed summary of the individual transactions is available on the company's website.
Market and Transaction Codes
The shares were purchased on the market identified by the MIC code XPAR. The transactions were carried out with ISIN FR0014000MR3. Complete information can be accessed through identified sources such as the Business Wire website.
Eurofins a rencontré des vents contraires importants et temporaires.
Malgré une croissance organique modérée, la rentabilité et les marges progressent.
Risks mentioned
Baisse de la demande en raison de conditions climatiques défavorables en Amérique du Nord.
Rationalisation des contrats dans les diagnostics cliniques en Espagne et en Italie.
Opportunities identified
Lancement de nouveaux contrats renforçant notre portefeuille BioPharma.
Initiatives de digitalisation et amélioration du réseau de laboratoires.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
